These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial. Abraldes JG, Albillos A, Bañares R, Turnes J, González R, García-Pagán JC, Bosch J. Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350 [Abstract] [Full Text] [Related]
27. Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis. Gatta A, Bolognesi M, Merkel C. Mol Aspects Med; 2008 May; 29(1-2):119-29. PubMed ID: 18036654 [Abstract] [Full Text] [Related]
35. [Morphology of portal hypertension at the early stage of liver damage induced by CCl4: an experimental study with dogs]. Zhang RP, Zhang WH, Xue DB, Wei YW. Zhonghua Yi Xue Za Zhi; 2004 Jul 02; 84(13):1118-21. PubMed ID: 15312518 [Abstract] [Full Text] [Related]
38. Splanchnic hyposensitivity to glypressin in a hemorrhage-transfused common bile duct-ligated rat model of portal hypertension: role of nitric oxide and bradykinin. Chen CT, Chu CJ, Lee FY, Chang FY, Wang SS, Lin HC, Hou MC, Wu SL, Chan CC, Huang HC, Lee SD. Hepatogastroenterology; 2009 Jul 02; 56(94-95):1261-7. PubMed ID: 19950773 [Abstract] [Full Text] [Related]
39. Hemodynamics in the isolated cirrhotic liver. Zipprich A. J Clin Gastroenterol; 2007 Jul 02; 41 Suppl 3():S254-8. PubMed ID: 17975473 [Abstract] [Full Text] [Related]